EVAX FY 2023 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena

EVAXEvaxion Biotech A/S

$20M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$73,000

Gross Profit

$73,000100.0% margin

Operating Income

-$22M-30406.8% margin

Net Income

-$22M-30308.2% margin

EPS (Diluted)

$-32.40

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$479,000

Balance Sheet

Total Assets

$13M

Total Liabilities

$18M

Stockholders' Equity

-$5M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73,000	$0	—
Gross Profit	$73,000	$0	—
Operating Income	-$22M	-$25M	+12.1%
Net Income	-$22M	-$23M	+4.5%